ShowcasesPricing
  1. US-listed companies
  2. HALOZYME THERAPEUTICS, INC.

HALOZYME THERAPEUTICS, INC.HALO

Market cap
$5.8B
P/E ratio
20.6x
Income statementBalance sheetCash flowOther
Raw aggregated data